These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 23358967)

  • 1. Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile Neutropenia.
    Doerflinger M; Haeusler GM; Li-Wai-Suen CSN; Clark JE; Slavin M; Babl FE; Allaway Z; Mechinaud F; Smyth GK; De Abreu Lourenco R; Phillips B; Pellegrini M; Thursky KA
    Front Immunol; 2021; 12():641879. PubMed ID: 34093531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing low-risk febrile neutropenia in children in the time of COVID-19: What matters to parents and clinicians.
    Haeusler GM; De Abreu Lourenco R; Bakos C; O'Brien T; Slavin MA; Clark JE; McMullan B; Borland ML; Babl FE; Krishnasamy M; Vanevski M; Thursky KA; Hall L
    J Paediatr Child Health; 2021 Jun; 57(6):826-834. PubMed ID: 33533525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules.
    Haeusler GM; Thursky KA; Slavin MA; Babl FE; De Abreu Lourenco R; Allaway Z; Mechinaud F; Phillips R;
    EClinicalMedicine; 2020 Jan; 18():100220. PubMed ID: 31993576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ReCAP: Hospitalizations in Older Adults With Advanced Cancer: The Role of Chemotherapy.
    O'Neill CB; Atoria CL; O'Reilly EM; Henman MC; Bach PB; Elkin EB; O'Neill CB; Atoria CL; O'Reilly EM; Henman MC; Bach PB; Elkin EB
    J Oncol Pract; 2016 Feb; 12(2):151-2; e138-48. PubMed ID: 26869655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV.
    Kern WV; Marchetti O; Drgona L; Akan H; Aoun M; Akova M; de Bock R; Paesmans M; Viscoli C; Calandra T
    J Clin Oncol; 2013 Mar; 31(9):1149-56. PubMed ID: 23358983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Good enough" medicine: noninferiority clinical trials and the management of fever and neutropenia.
    Mullen CA
    Pediatr Blood Cancer; 2012 Sep; 59(3):415-6. PubMed ID: 22422727
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.
    Sebban C; Dussart S; Fuhrmann C; Ghesquieres H; Rodrigues I; Geoffrois L; Devaux Y; Lancry L; Chvetzoff G; Bachelot T; Chelghoum M; Biron P
    Support Care Cancer; 2008 Sep; 16(9):1017-23. PubMed ID: 18197434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the penetration of fluoroquinolones in human conjunctival tissue.
    Fiscella RG; Jensen MK
    Arch Ophthalmol; 2006 Dec; 124(12):1796-7; author reply 1797. PubMed ID: 17159052
    [No Abstract]   [Full Text] [Related]  

  • 9. First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.
    Brack E; Bodmer N; Simon A; Leibundgut K; Kühne T; Niggli FK; Ammann RA
    Pediatr Blood Cancer; 2012 Sep; 59(3):423-30. PubMed ID: 22271702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient therapy for fever and neutropenia is safe but implementation is the key.
    Slavin MA; Thursky KA
    J Clin Oncol; 2013 Mar; 31(9):1128-9. PubMed ID: 23358967
    [No Abstract]   [Full Text] [Related]  

  • 11. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
    Mullen CA
    Pediatr Infect Dis J; 2003 Dec; 22(12):1138-42. PubMed ID: 14688588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based review of moxifloxacin.
    O'Brien TP
    Int Ophthalmol Clin; 2006; 46(4):61-72. PubMed ID: 17060792
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.